Opiant Pharmaceuticals (@OpiantPharma) header
Opiant Pharmaceuticals (@OpiantPharma) profile picture

Opiant Pharmaceuticals

@OpiantPharma

The company that developed NARCAN® Nasal Spray, we're working on medicines to treat addictions and drug overdose.

 London, United Kingdom
opiant.co.uk
Joined April 2016
  • Tweets29
  • Following165
  • Followers281
1Media
Photo by Opiant Pharmaceuticals (@OpiantPharma)
Our CEO RogerCrystalMD spoke with @gpbnews about the #opioidcrisis, the devastating rise in overdose deaths caused by stronger, longer-lasting synthetic opioids like #fentanyl, & how Opiant is committed to addressing overdose and addiction. Listen here: bit.ly/3NYOFxA

Stronger opioid reversal drugs are needed to combat the fentanyl crisis, Narcan developer says

Between early February and mid-March, at least 66 emergency department visits in Georgia involved the use of cocaine, methamphetamine, crack, heroin, pain killers and cannabis products that were...

gpb.org
Our CEO, Roger Crystal, recently spoke with @PharmaScripto discuss what the future holds for pharma in 2022, urging that pandemic learnings are applied to deal with the #opioidepidemic. bit.ly/3LMO0Ny
A new @NIH study with NIDA shows an overwhelming increase, nearly 50-fold, in pills seized containing illicit #fentanyl between January 2018 and December 2021. Read more below. #EndOverdose #PublicHealth
NIDAnews (@NIDAnews) profile pictureNIDAnews
@NIDAnews31 Mar 2022
The number of pills containing fentanyl seized by law enforcement increased dramatically between 2018 and 2021, highlighting a growing, dangerous trend – particularly for people new to drug use. Read more about the NIDA-funded study @DrugAlcoholDep: loom.ly/nSIzwCY
Image from NIDAnews (@NIDAnews)
As @NIDAnews National Drug and Alcohol Facts Week draws to a close, our CEO discusses the importance, and urgency, of talking with today's youth about drug use. #NDAFW bit.ly/3wBj26T
Image from Opiant Pharmaceuticals (@OpiantPharma)

No more items